Trial Profile
Lutonix or Inpact for tHE tReatment Of fEmeropopliteal Stenosis - DCB
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Peripheral arterial disorders
- Focus Therapeutic Use
- Acronyms HEROES-DCB
- 29 Mar 2017 New trial record